Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00989157 · ClinicalTrials.gov registry record · Phase 3
Effects of Gastric Bypass on Blood Levels of Duloxetine
A Phase 3 study of Bariatric Surgery, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00989157 is a Phase 3 study of Bariatric Surgery that has completed, run by Neuropsychiatric Research Institute, Fargo, North Dakota. The registered enrollment target is 20 participants, below the 98-participant average among 15 other Bariatric Surgery trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00989157, a Phase 3 study of Bariatric Surgery, has completed, sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to determine the difference, if any, in the pharmacokinetics of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
Conditions Studied
Interventions
- DRUG Duloxetine
Study Locations (1)
North Dakota
- Neuropsychiatric Research Institute - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00989157
The ClinicalTrials.gov registry entry for NCT00989157 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 98-participant average among 15 other Bariatric Surgery trials with a reported enrollment target (80% lower). The listed sponsor is Neuropsychiatric Research Institute, Fargo, North Dakota, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bariatric Surgery appearing as the primary indexed condition, and to 1 intervention - of which Duloxetine is the first listed.
NCT00989157 reports 1 study location spanning 1 distinct geographic area - top geographies include North Dakota.
Frequently Asked Questions
What is clinical trial NCT00989157 about?
NCT00989157 is a clinical study titled "Effects of Gastric Bypass on Blood Levels of Duloxetine". This study aims to determine the difference, if any, in the pharmacokinetics of duloxetine between patients who are nine to fifteen months post Roux-en-Y Bariatric Surgery and control subjects matched for body mass index (BMI), age and gender.
What is the current status of trial NCT00989157?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2009-09. Estimated completion is 2012-11.
What conditions does trial NCT00989157 study?
This clinical trial studies the following conditions: Bariatric Surgery.
What interventions are being tested in trial NCT00989157?
The interventions under investigation include: Duloxetine (DRUG).
Who is sponsoring clinical trial NCT00989157?
This trial is sponsored by Neuropsychiatric Research Institute, Fargo, North Dakota, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00989157 being conducted?
This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bariatric Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
Physiologic Response to Bariatric Surgery and the Impact of Adjunct Semaglutide in Adolescents
RECRUITING · Phase 1
-
Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients
RECRUITING · Phase 2
-
2024 Tirzepatide-Bariatric Surgery
RECRUITING · Phase 4
-
Lexion AP 50/30 Warmed Humidified Real Time CO2 Insufflation vs Airseal Recirculated CO2/Air Insufflation in Minimally Invasive Bariatric (Gastric Bypass) Surgery
RECRUITING · NA
-
Simethicone as Part of ERAS in Bariatric Surgery Patients
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.